National Marrow Donor Program

National Marrow Donor Program, doing business as Nmdp (also known as Be The Match), is a Minneapolis-based nonprofit organization that operates the nation's largest bone marrow registry and delivers hematopoietic stem cell transplantation services to federal agencies as a prime contractor (91% of recent awards) and as a sub-recipient in clinical research networks. Nmdp competes exclusively full-and-open without set-asides across its federal portfolio.

Nmdp's core capabilities center on bone marrow and cord blood donor recruitment, tissue typing, stem cell collection and transportation, unrelated donor search coordination, registry maintenance, and marrow transplant services. Representative prime work includes a $125.8 million definitive contract with the Health Resources and Services Administration (HRSA) awarded September 30, 2022 through March 29, 2028 to establish and maintain an electronic Single Point of Access-Coordinating Center (SPA-CC) system enabling healthcare professionals to search for adult bone marrow donors and cord blood units—work performed in Rockville, Maryland with SCI-reported FY2024 labor of 74.2 FTEs and 154,366 contractor hours invoiced at $21.6 million. An $8.9 million HRSA definitive contract awarded September 29, 2022 through March 28, 2028 established the Office of Patient Advocacy within the C.W. Bill Young Cell Transplantation Program to deliver patient advocacy, case management, and education support for patients searching for donors. Recurring firm fixed-price purchase orders from the Department of Veterans Affairs Veterans Integrated Service Network 9 maintain a registry of HLA-typed hematopoietic stem cells for unrelated transplantation; the most recent award reached $2 million (May 1, 2026 through April 30, 2027). Defense Health Agency and Army Medical Command issue regular purchase orders for individual bone marrow transplant services and peripheral blood stem cell collection, typically valued in the $150,000 to $300,000 range per order.

Customer concentration is extreme: HRSA Headquarters accounts for 99% of combined potential value across all awards ($493 million across 13 awards), while the Veterans Integrated Service Network 9 ranks second at $8.1 million (8 awards). By award count, the Department of the Army Medical Command leads with 55 awards ($4.6 million combined potential value), followed by Air Force Air Education and Training Command with 40 awards ($2.5 million), and HRSA's National Heart Lung and Blood Institute with 14 awards ($6.3 million). The portfolio covers 19 distinct customer agencies, including the Department of Defense, Veterans Affairs, Health and Human Services, and Office of Naval Research.

Activity has remained stable year-over-year at 13–15 awards annually through FY2024, declining to 9 awards in FY2025 and 7 in FY2026 year-to-date. Six awards (combined potential value $137.4 million) carry completion dates within the next twenty-four months, presenting significant recompete exposure centered on the HRSA SPA-CC contract as its primary renewal risk. The vast majority of Nmdp's obligations exceed its stated potential values (181% ratio of obligated to potential value), indicating frequent task-order extensions and price adjustments across the Defense Health Agency and Army Medical Command purchase-order portfolio.

On SCI-reportable federal service contracts above the $150,000 threshold, Nmdp invoiced $81.7 million across prime records spanning FY2022 through FY2024 ($32.2 million in FY2022, $26 million in FY2023, $23.6 million in FY2024). The dataset shows roughly 75.7 FTEs in FY2022 rising to 106 FTEs in FY2024 across both prime and sub records, reflecting scale-up on the HRSA coordination centers. Government-paid hourly rates on prime contracts derived from invoiced dollars and hours run median around $101.70 per hour, with rates ranging from $52.68 at the 10th percentile to $233.97 at the 90th percentile, reflecting mixed labor pools spanning clinical coordinators, administrative staff, and senior medical science leadership. Nmdp self-performed all SCI-reported prime hours with zero sub-engagement across those contracts.

As a subcontractor, Nmdp operates under The Medical College of Wisconsin and Fred Hutchinson Cancer Center on grant sub-awards supporting the Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center and clinical trials in severe aplastic anemia, pediatric transplantation, and severe combined immunodeficiency research. Nmdp also subcontracts to Beckman Coulter on CAR-T cell therapy clinical trial site administration and cell distribution logistics. Federal grant work includes Office of Naval Research project awards (CFDA 12.300) for development of medical technology for contingency response to marrow toxic substances (most recent $2.88 million award February 1, 2025), cooperative agreements with the National Heart Lung and Blood Institute on pediatric hematopoietic cell transplantation consortia, and cooperative agreements with the National Institute of Allergy and Infectious Diseases on clinical trials in severe combined immunodeficiency preparative approaches.